Kumar CC. Genetic Abnormalities and challenges in the treatment of Acute myeloid leukemia. Genes Cancer. 2011;2(2):95.
Article CAS PubMed PubMed Central Google Scholar
Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):577.
Padda J, Khalid K, Kakani V, et al. Metabolic Acidosis Leuk Cureus. 2021;13(9):e17732.
Dong Y, Shi O, Zeng Q, et al. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020;9(1):1–11.
Schneider P, Castro PG, Pinhanços SM, et al. Decitabine mildly attenuates MLL-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer. EJHaem. 2020;1(2):527–36.
Article CAS PubMed PubMed Central Google Scholar
Rogstad DK, Herring JL, Theruvathu JA, et al. Chemical decomposition of 5-aza-2’-deoxycytidine (decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry. Chem Res Toxicol. 2009;22(6):1194–204.
Article CAS PubMed PubMed Central Google Scholar
Panchal K, Katke S, Dash SK, et al. An expanding horizon of complex injectable products: development and regulatory considerations. Drug Deliv Transl Res. 2023;13:433–72.
Chaurasiya A, Patra P, Thathireddy P. PLGA-Based Micro- and Nano-particles From Lab to Marke. In: Arvind NKM, editor. Micro- and Nanotechnologies-Based Product Development. CRC; 2021. p. 326.
Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377.
Article CAS PubMed Google Scholar
Padín-González E, Lancaster P, Bottini M, et al. Understanding the role and impact of Poly (Ethylene Glycol) (PEG) on nanoparticle formulation: implications for COVID-19 vaccines. Front Bioeng Biotechnol. 2022;10:882363.
Article PubMed PubMed Central Google Scholar
Essa D, Kondiah PPD, Choonara YE. The design of poly(lactide-co-glycolide) nanocarriers for medical applications. Front Bioeng Biotechnol. 2020;8:503602.
Waghule T, Dabholkar N, Gorantla S, et al. Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): a risk based industrial approach. Biomed Pharmacother. 2021;141:111940.
Article CAS PubMed Google Scholar
Srinivas NSK, Verma R, Kulyadi GP. A quality by design approach on polymeric nanocarrier delivery of gefitinib formulation in vitro and in vivo characterization. Int J Nanomed. 2017;12:15.
Park SJ, Choo GH, Hwang SJ. Quality by design: screening of critical variables and formulation optimization of Eudragit nanoparticles containing dutasteride. Arch Pharm Res. 2013;36:593–601.
Article CAS PubMed Google Scholar
Mishra SM, Rohera BD. An integrated quality by design (QbD) approach for design development and optimization of orally disintegrating tablet formulation of carbamazepine. Pharm Dev Technol. 2017;22:889–903.
Article CAS PubMed Google Scholar
Jena GK, Patra CN, Panigrahi KC, et al. QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of Capecitabine for antitumor activity. Drug Deliv Transl Res. 2022;12(6):1521–39.
Article CAS PubMed Google Scholar
Chen C, Yang W, Wang DT et al. A modified spontaneous emulsification solvent diffusion method for the preparation of curcumin-loaded PLGA nanoparticles with enhanced in vitro anti-tumor activity. Front Mater Sci 2014; 8:332–42.
Kaur A, Bhoop BS, Chhibber S, et al. Supramolecular nano-engineered lipidic carriers based on diflunisal-phospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. Int J Pharm. 2017;533(1):206–24.
Article CAS PubMed Google Scholar
Panchal K, Reddy A, Chaurasiya A. Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product. Drug Deliv Transl Res. 2024.
Nugraheni Raditya W, Setyawan D, Yusuf H. Physical characteristics of liposomal formulation dispersed in HPMC Matrix and Freeze-dried using maltodextrin and Mannitol as Lyoprotectant. Pharm Sci. 2017;23:285–92.
De Jonge N, Ross FM. Electron microscopy of specimens in liquid. Nat Nanotechnol 2011;6:695–704.
Alimunnisa A, Rao L. RP-HPLC Method Development and Validation for simultaneous determination of decitabine and cedazuridine in pure and Tablet Dosage Form. Curr Trends Biotechnol Pharm. 2022;16(2):31–9.
Purushothaman M, Viswanath V, Narashimha Rao B. Preparation and evaluation of decitabine liposomes. IAJPS. 2015;2(9):1264–73.
Shukla R, Gupta J, Shukla P. Chitosan coated alginate micro particles for the oral delivery of antifilarial drugs and combinations for intervention in Brugia malayi induced lymphatic filariasis. RSC Adv. 2015;5:69047–56.
Brus J, Czernek J, Kobera L, et al. Predicting the Crystal structure of decitabine by powder NMR crystallography: influence of Long-Range Molecular Packing Symmetry on NMR parameters. Cryst Growth Des. 2016;16(12):7102–11.
Chaurasiya A, Gorajiya A, Jayabalan N. In: Saurabh, Srivastava, editors. Stability Testing Parameters of Nano scaled Product Development in: Neelesh Kumar Mehra. Multifunctional Nanocarriers. Elsevier; 2022. pp. 475–500.
Roosendaal J, Wang K, Rosing H. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β-decitabine in human plasma, whole blood and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1109:132–41.
Article CAS PubMed Google Scholar
Liu G, McEnnis K. Glass Transition Temperature of PLGA Particles and the influence on drug delivery applications. Polym (Basel). 2022;14(5):993.
留言 (0)